ICI Pharmaceuticals
Executive Summary
Former Abbott Medical Director Ronald Krall, MD, to ICI Pharmaceuticals Group Americas Vice President-Clinical/Medical Affairs. Boehringer Ingelheim's John Weet, PhD, joins as Director of Drug Regulatory Affairs, reporting to VP-Drug Regulatory Affairs William Kennedy.